Table 2.
Evaluation and approval of the application by the National ALS Registry review committee.
| Evaluation | Criteria |
| 1. Scientific merit (A-D is considered acceptable) | A. Outstanding/B. Excellent/C. Good/D. Acceptable/E. Unacceptable |
| 2. Will the proposal provide useful information for ALSa patients? (A-C is considered acceptable) | A. High potential/B. Strong potential/C. Good potential/D. Limited potential/E. No apparent potential |
| 3. Are the patient contact procedures and materials clear? | Yes/No/Requires more information |
| 4. Are the patient contact procedures and materials appropriate, necessary, and sufficient? | Yes/No/Requires more information |
| 5. In your judgment, would most ALS patients find the demands of the protocol reasonable? | Yes/No/Requires more information |
| 6. Is there an acceptable risk/benefit ratio? | Yes/No/Requires more information |
| 7. Are there adequate protections for patient confidentiality and privacy? | Yes/No/Requires more information |
| 8. Does the proposal reach a satisfactory threshold for all 7 criteria listed above? | Yes/No |
| 9. Do you support approval of the proposal as it has been submitted? | Yes/No |
| Comments for the investigators (limit of 500 words) |
|
aALS: amyotrophic lateral sclerosis.